MAL2 and breast carcinoma: Interesting, we found that there was a broad cytoplasmic expression of MAL2 in carcinoma tissues of CRC, while rare in non-cancerous tissues, which was also reported in breast cancer [11] and renal cell cancer [17], suggesting that the oncogenic function of MAL2 was carried out in the cytoplasm.